Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Read more about Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.
Hypoxia in models of lung cancer: implications for targeted therapeutics. Read more about Hypoxia in models of lung cancer: implications for targeted therapeutics.
Therapeutic targeting of the DNA mismatch repair pathway. Read more about Therapeutic targeting of the DNA mismatch repair pathway.
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer. Read more about A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.
Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Read more about Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Read more about Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.
A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Read more about A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.
Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Read more about Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Read more about Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans.
New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors. Read more about New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.
